Article Detail - JE Part B
MolDX: Signatera and Minimal Residual Disease Testing for Colorectal Cancer Proposed LCD Retirement - Effective August 5, 2020
This proposed Local Coverage Determination (LCD) has been retired under contractor 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Medicare Coverage Database (MCD) Number: DL38343
LCD Title: MolDX: Signatera and Minimal Residual Disease Testing for Colorectal Cancer
Effective Date: August 5, 2020
LCDs are retired due to lack of evidence of current need(s) for the education and/or edits or in some cases because the material is addressed by a National Coverage Determination (NCD), a coverage provision in a CMS interpretative manual, another LCD, or an article. Retirement does not mean that medical necessity has changed or that the LCD no longer reflects appropriate criteria. The guidance in the retired LCD may be helpful in assessing medical necessity.
To access retired proposed LCDs, visit the CMS Medicare Coverage Database Archive.
Last Updated Thu, 13 Aug 2020 15:49:57 +0000